Propionic Acid

Propionic Acid

SCHEMBL1099676

CCC(=O)O.Fc1cccc(Cn2ccc3cc(F)cnc32)c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.45
MAOB P27338 1/20 0.45
PDE1C Q14123 2/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
JAK2 O60674 2/20 0.43
JAK1 P23458 2/20 0.43
TYK2 P29597 2/20 0.43
JAK3 P52333 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
STAT6 P42226 2/20 0.42
FGFR1 P11362 1/20 0.42
FGFR4 P22455 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
OPRD1 P41143 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL1099553 0.88 MAPK14 (0.43) GLO1MAOBPDE1CPDE1APDE1B
Ethoxycarbonyl Group SCHEMBL27749326 0.76 METAP2 (0.38) GLO1JAK2TYK2JAK3FGFR1
SCHEMBL27790858 0.76 MAPK14 (0.45) GLO1MAOBPDE1CPDE1APDE1B
SCHEMBL1104760 0.74 KDM4E (0.56) MAOBPDE1CSTAT6KDM4EALDH1A1
SCHEMBL38652180 0.74 KDM4E (0.56) MAOBPDE1CSTAT6KDM4EALDH1A1
SCHEMBL1100706 0.73 CCR2 (0.47) PDE1CKDM4EL3MBTL1CYP1A2CYP3A4
SCHEMBL24824870 0.73 HTR2C (0.36) GLO1STAT6FGFR1FGFR4
SCHEMBL1099674 0.72 FFAR1 (0.42) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
Propionic Acid SCHEMBL1101029 0.72 EPHX2 (0.46) MAOBPDE1CPDE1APDE1BEPHX2
Propionic Acid SCHEMBL1100328 0.71 GRIN1 (0.40) FGFR1FGFR4ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716273-B2 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy SANOFI (FR) 2014-05-06 US disclosed
US-8716272-B2 N-(amino-heteroaryI)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy SANOFI (FR) 2014-05-06 US disclosed
US-20120142669-A1 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy SANOFI-AVENTIS (FR) 2012-06-07 US disclosed
US-20120142670-A1 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy SANOFI-AVENTIS (FR) 2012-06-07 US disclosed
US-8153650-B2 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy SANOFI-AVENTIS (FR) 2012-04-10 US disclosed
US-20100041634-A1 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy SANOFI-AVENTIS (FR) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142670-A1 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy ZYX, NQO2, PYCR1 GLO1 3051/4885MAOB 109/4885PDE1C 2801/4885
US-20120142669-A1 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy ZYX, NQO2, PYCR1 GLO1 3051/4885MAOB 109/4885PDE1C 2801/4885
US-20100041634-A1 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy ZYX, NQO2, PYCR1 GLO1 3051/4885MAOB 109/4885PDE1C 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.